For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211109:nRSI8057Ra&default-theme=true
RNS Number : 8057R Morgan Stanley Europe SE 09 November 2021
9 November 2021
Thermo Fisher Scientific (Finance I) B.V.
Pre-stabilisation Period Announcement
Morgan Stanley Europe SE (contact: Morgan Stanley Debt Syndicate - Florian
Hessel; telephone: +49 69 2166 1287) hereby gives notice, as Coordinating
Stabilisation Manager, that the Stabilisation Manager(s) named below may
stabilise the offer of the following securities in accordance with Commission
Delegated Regulation (EU) 2016/1052 of 8 March 2016 supplementing Regulation
(EU) No 596/2014 and the UK FCA Stabilisation Binding Technical Standards.
Securities
Issuer: Thermo Fisher Scientific (Finance I) B.V.
Guarantor (if any): Thermo Fisher Scientific Inc.
Aggregate nominal amount: TBC
Description: EUR • Floating Rate Senior Notes due 20 •
EUR • • % Senior Notes due 20 •
EUR • % Senior Notes due 20 •
Offer price: TBC
Stabilisation
Stabilisation Manager(s): Morgan Stanley Europe SE
Barclays Bank PLC
BofA Securities Europe SA
Citigroup Global Markets Europe AG
Mizuho Securities Europe GmbH
BNP Paribas
Credit Suisse Bank (Europe), S.A.
Deutsche Bank Aktiengesellschaft
HSBC Bank plc
ING Bank N.V., Belgian Branch
MUFG Securities (Europe) N.V.
SMBC Nikko Capital Markets Europe GmbH
U.S. Bancorp Investments, Inc.
Wells Fargo Securities Europe S.A.
Stabilisation period expected to start on: 9 November 2021
Stabilisation period expected to end no later than: 18 December 2021
Existence, maximum size and conditions of use of over-allotment facility: The Stabilisation Manager may over-allot the securities to the extent
permitted in accordance with applicable laws and rules.
Stabilisation trading venue: Global Exchange Market of Euronext Dublin
In connection with the offer of the above securities, the Stabilisation
Manager(s) may over-allot the securities or effect transactions with a view to
supporting the market price of the securities during the stabilisation period
at a level higher than that which might otherwise prevail. However,
stabilisation may not necessarily occur and any stabilisation action, if
begun, may cease at any time. Any stabilisation action or over-allotment
shall be conducted in accordance with all applicable laws and rules.
This announcement is for information purposes only and does not constitute an
invitation or offer to underwrite, subscribe for or otherwise acquire or
dispose of any securities of the Issuer in any jurisdiction.
This announcement and the offer of the securities to which it relates are only
addressed to and directed at persons outside the United Kingdom and persons in
the United Kingdom who have professional experience in matters related to
investments or who are high net worth persons within Article 12(5) of the
Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and
must not be acted on or relied on by other persons in the United Kingdom.
In addition, if and to the extent that
this announcement is communicated in, or the offer of the
securities to which it relates is made in, any EEA Member State before the publication of a prospectus in relation
to the securities which
has been approved by the competent authority in that Member
State in accordance with Regulation (EU) 2017/1129 (the "EEA Prospectus
Regulation") (or which has been approved by a competent authority
in another Member State and notified to the competent authority
in that Member State in accordance with the EEA
Prospectus Regulation), this announcement and the offer are only addressed to and directed at
persons in that Member State
who are qualified investors within the meaning of the EEA Prospectus
Regulation (or who are other persons to whom the offer may
lawfully be addressed) and must not be acted on or relied on
by other persons in that Member State.
In addition, if and to the extent that
this announcement is communicated in, or the offer of the
securities to which it relates is made in, the UK
before the publication of a prospectus in relation
to the securities which
has been approved by the competent authority in the UK
in accordance with Regulation (EU) 2017/1129 as it forms part of domestic
law by virtue of the European Union (Withdrawal) Act 2018 (the "UK Prospectus
Regulation"), this announcement and the offer are only addressed to and directed at
persons in the UK who are qualified investors within the meaning of
the UK Prospectus
Regulation (or who are other persons to whom the offer may
lawfully be addressed) and must not be acted on or relied on
by other persons in the UK.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END STABLBMTMTJMBPB